• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于感染性角膜炎交联的光活化发色团及其作为治疗微生物性角膜炎的一种治疗方式的疗效。

Photo-activated chromophore for infectious keratitis cross-linking and its efficacy as a treatment modality in managing microbial keratitis.

作者信息

Saini Sanchita, Singh Satyaprakash, Dwivedi Kshama, Singh Sanskriti, Kumar Santosh, Rana Jagriti

机构信息

Department of Ophthalmology, King George Medical College, Lucknow, Uttar Pradesh, India.

Department of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.

出版信息

Indian J Ophthalmol. 2022 May;70(5):1571-1577. doi: 10.4103/ijo.IJO_2693_21.

DOI:10.4103/ijo.IJO_2693_21
PMID:35502028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9333004/
Abstract

PURPOSE

To assess Photo Activated Chromophore for Infective Keratitis-Cross Linking (PACK-CXL) and its efficacy as a treatment modality in managing microbial keratitis.

METHODS

Single Centre prospective interventional study in infectious keratitis. A total of eleven patients were taken who had corneal thickness (CT) more than 400μm. PACK-CXL was performed according to Dresden's protocol. The response was assessed by slit lamp examination, BCVA and AS-OCT at the time of complete healing.

RESULTS

The mean visual acuity at presentation was 1.207logMAR (0.3-3) which improved to mean value of 0.53logMAR (0.3-1). Mean time taken for complete epithelization was 17.45 days (14- 30 days) and that for complete healing was 33.72 days (21- 60 days). Mean CT at the baseline was 650.5± 108μm which reduced on consecutive follow up visits. There was reduction in the symptoms in nine patients except in two. One case reported increase in symptoms with worsening increase in endoexudates and hypopyon, and the other developed drug toxicity due to topical medications.

CONCLUSION

Patients who underwent PACK-CXL showed good and early healing, good remodelling of cornea and improved visual acuity. The recalcitrant cases became responders to the same medications after PACK-CXL. Thus, PACK-CXL works well for both fungal and bacterial keratitis.

摘要

目的

评估用于感染性角膜炎的光活化色团交联术(PACK-CXL)及其作为治疗微生物性角膜炎的一种治疗方式的疗效。

方法

对感染性角膜炎进行单中心前瞻性干预研究。共纳入11例角膜厚度(CT)超过400μm的患者。PACK-CXL按照德累斯顿方案进行。在完全愈合时通过裂隙灯检查、最佳矫正视力(BCVA)和眼前节光学相干断层扫描(AS-OCT)评估反应情况。

结果

就诊时的平均视力为1.207logMAR(0.3 - 3),改善至平均0.53logMAR(0.3 - 1)。完全上皮化的平均时间为17.45天(14 - 30天),完全愈合的平均时间为33.72天(21 - 60天)。基线时的平均角膜厚度为650.5±108μm,在连续随访中逐渐降低。除2例患者外,9例患者的症状有所减轻。1例患者报告症状加重,伴有眼内渗出物增加和前房积脓,另1例因局部用药出现药物毒性。

结论

接受PACK-CXL治疗的患者显示出良好且早期的愈合、角膜的良好重塑以及视力改善。难治性病例在PACK-CXL后对相同药物有反应。因此,PACK-CXL对真菌性和细菌性角膜炎均有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/585f7b2d6ff1/IJO-70-1571-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/5d1ccbf958c6/IJO-70-1571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/bff7f903478b/IJO-70-1571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/92a928b49155/IJO-70-1571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/41af1e1066de/IJO-70-1571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/d0d0c368c536/IJO-70-1571-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/3a9192c46da9/IJO-70-1571-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/0efaec7decde/IJO-70-1571-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/126ef0a0b938/IJO-70-1571-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/585f7b2d6ff1/IJO-70-1571-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/5d1ccbf958c6/IJO-70-1571-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/bff7f903478b/IJO-70-1571-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/92a928b49155/IJO-70-1571-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/41af1e1066de/IJO-70-1571-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/d0d0c368c536/IJO-70-1571-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/3a9192c46da9/IJO-70-1571-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/0efaec7decde/IJO-70-1571-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/126ef0a0b938/IJO-70-1571-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d570/9333004/585f7b2d6ff1/IJO-70-1571-g009.jpg

相似文献

1
Photo-activated chromophore for infectious keratitis cross-linking and its efficacy as a treatment modality in managing microbial keratitis.用于感染性角膜炎交联的光活化发色团及其作为治疗微生物性角膜炎的一种治疗方式的疗效。
Indian J Ophthalmol. 2022 May;70(5):1571-1577. doi: 10.4103/ijo.IJO_2693_21.
2
Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis.光激活色基角膜交联术(PACK-CXL)治疗严重角膜炎。
Acta Ophthalmol. 2019 Nov;97(7):721-726. doi: 10.1111/aos.14001. Epub 2018 Dec 28.
3
Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis.光激活染色剂在感染性角膜炎中的应用-角膜交联术(PACK-CXL):系统评价和荟萃分析。
Ocul Surf. 2019 Oct;17(4):624-634. doi: 10.1016/j.jtos.2019.08.006. Epub 2019 Aug 8.
4
Repeated sessions of PACK-CXL WA for the treatment of resistant bacterial keratitis: a retrospective study.重复使用 PACK-CXL WA 治疗耐药性细菌性角膜炎:一项回顾性研究。
BMC Ophthalmol. 2023 Jul 26;23(1):333. doi: 10.1186/s12886-023-03080-3.
5
Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting.光活化核黄素交联(PACK-CXL)治疗伴有角膜融解的进展性感染性角膜炎。
Ophthalmology. 2014 Jul;121(7):1377-82. doi: 10.1016/j.ophtha.2014.01.011. Epub 2014 Feb 25.
6
Corneal Collagen Cross-Linking With Photoactivated Chromophore for Infectious Keratitis After Penetrating Keratoplasty.经穿透性角膜移植术后感染性角膜炎的光激活色原体角膜胶原交联。
Cornea. 2020 Mar;39(3):283-289. doi: 10.1097/ICO.0000000000002210.
7
Current and Future Applications of Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL): An Overview of the Different Treatments Proposed.光活化发色团在角膜炎-角膜胶原交联(PACK-CXL)中的当前及未来应用:对所提出的不同治疗方法的概述
Semin Ophthalmol. 2018;33(3):293-299. doi: 10.3109/08820538.2015.1123731. Epub 2016 Apr 19.
8
Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.比较角膜胶原交联术(PACK-CXL)与伏立康唑治疗实验性真菌性角膜炎的效果。
Acta Ophthalmol. 2019 Feb;97(1):e91-e96. doi: 10.1111/aos.13829. Epub 2018 Jun 4.
9
Accelerated Corneal Cross-linking as an Adjunct Therapy in the Management of Presumed Bacterial Keratitis: A Cohort Study.加速性角膜交联术作为疑似细菌性角膜炎治疗的辅助疗法:一项队列研究。
J Refract Surg. 2020 Apr 1;36(4):258-264. doi: 10.3928/1081597X-20200226-02.
10
Collagen Cross-linking With Photoactivated Riboflavin (PACK-CXL) for Bacterial Keratitis After Small Incision Lenticule Extraction (SMILE).光活化核黄素胶原交联术(PACK-CXL)用于小切口基质透镜切除术(SMILE)后细菌性角膜炎的治疗
J Refract Surg. 2017 Apr 1;33(4):278-280. doi: 10.3928/1081597X-20170126-01.

引用本文的文献

1
Post-Keratoplasty Microbial Keratitis in the Era of Lamellar Transplants-A Comprehensive Review.板层移植时代的角膜移植术后微生物性角膜炎——一项全面综述
J Clin Med. 2024 Apr 17;13(8):2326. doi: 10.3390/jcm13082326.
2
Accelerated high fluence photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) at the slit lamp: a pilot study.裂隙灯下用于感染性角膜炎-角膜交联(PACK-CXL)的加速高能量光活化发色团:一项初步研究。
Front Pharmacol. 2023 Sep 7;14:1229095. doi: 10.3389/fphar.2023.1229095. eCollection 2023.

本文引用的文献

1
Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis.角膜交联术作为真菌性角膜炎治疗辅助疗法的评估。
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1443-1452. doi: 10.1007/s00417-019-04314-1. Epub 2019 Apr 30.
2
Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis.光激活色基角膜交联术(PACK-CXL)治疗严重角膜炎。
Acta Ophthalmol. 2019 Nov;97(7):721-726. doi: 10.1111/aos.14001. Epub 2018 Dec 28.
3
Spectral Domain Anterior Segment Optical Coherence Tomography in Fungal Keratitis.
真菌性角膜炎的频域眼前节光学相干断层扫描
Cornea. 2018 Nov;37(11):1388-1394. doi: 10.1097/ICO.0000000000001715.
4
Corneal Collagen Cross-Linking for the Management of Mycotic Keratitis.角膜胶原交联治疗真菌性角膜炎。
Mycopathologia. 2018 Jun;183(3):521-527. doi: 10.1007/s11046-018-0247-8. Epub 2018 Feb 16.
5
Accelerated Corneal Cross-Linking With Photoactivated Chromophore for Moderate Therapy-Resistant Infectious Keratitis.用于中度治疗抵抗性感染性角膜炎的光活化发色团加速角膜交联
Cornea. 2018 Apr;37(4):528-531. doi: 10.1097/ICO.0000000000001498.
6
Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial.用于中重度感染性角膜炎辅助治疗的光活化发色团:一项随机对照试验
Am J Ophthalmol. 2016 May;165:94-9. doi: 10.1016/j.ajo.2016.02.030. Epub 2016 Mar 3.
7
Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers.紫外线A/核黄素胶原交联术治疗中度细菌性角膜溃疡
Cornea. 2015 Apr;34(4):402-6. doi: 10.1097/ICO.0000000000000375.
8
Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting.光活化核黄素交联(PACK-CXL)治疗伴有角膜融解的进展性感染性角膜炎。
Ophthalmology. 2014 Jul;121(7):1377-82. doi: 10.1016/j.ophtha.2014.01.011. Epub 2014 Feb 25.
9
Photo-activated riboflavin therapy of refractory corneal ulcers.光激活核黄素治疗难治性角膜溃疡。
Cornea. 2012 Oct;31(10):1210-3. doi: 10.1097/ICO.0b013e31823f8f48.
10
UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.UVA-核黄素光化学疗法治疗细菌性角膜炎:一项初步研究。
Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):95-102. doi: 10.1007/s00417-011-1754-1. Epub 2011 Aug 27.